Hematopoietic and Lymphoid Cell Neoplasm Clinical Trials

36 recruiting

Hematopoietic and Lymphoid Cell Neoplasm Trials at a Glance

36 actively recruiting trials for hematopoietic and lymphoid cell neoplasm are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Houston, Columbus, and Baltimore. Lead sponsors running hematopoietic and lymphoid cell neoplasm studies include M.D. Anderson Cancer Center, Fred Hutchinson Cancer Center, and Alliance for Clinical Trials in Oncology.

Browse hematopoietic and lymphoid cell neoplasm trials by phase

Treatments under study

About Hematopoietic and Lymphoid Cell Neoplasm Clinical Trials

Looking for clinical trials for Hematopoietic and Lymphoid Cell Neoplasm? There are currently 36 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hematopoietic and Lymphoid Cell Neoplasm trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hematopoietic and Lymphoid Cell Neoplasm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 36 trials

Recruiting
Phase 1

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Phase 3

Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
University of Rochester NCORP Research Base400 enrolled153 locationsNCT04829539
Recruiting
Early Phase 1

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

Hematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center24 enrolled1 locationNCT04744116
Recruiting
Phase 1

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed+4 more
M.D. Anderson Cancer Center30 enrolled1 locationNCT05101213
Recruiting

Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

Hematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center100 enrolled1 locationNCT04888338
Recruiting
Phase 1Phase 2

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection+2 more
M.D. Anderson Cancer Center70 enrolled1 locationNCT04565665
Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Head and Neck CarcinomaMalignant Solid NeoplasmSarcoma+59 more
Alliance for Clinical Trials in Oncology2,000 enrolled745 locationsNCT05334069
Recruiting
Not Applicable

Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Neoplasm in the Spine
Ohio State University Comprehensive Cancer Center200 enrolled1 locationNCT05178472
Recruiting

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

Hematopoietic and Lymphoid Cell NeoplasmMalignant NeoplasmHealthy Subject+2 more
University of Southern California625 enrolled1 locationNCT03207854
Recruiting

Role of Gut Microbiome in Cancer Therapy

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
Mayo Clinic3,000 enrolled3 locationsNCT05112614
Recruiting
Not Applicable

Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center256 enrolled1 locationNCT02464696
Recruiting
Phase 2

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

Hematopoietic and Lymphoid Cell NeoplasmAdvanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center312 enrolled1 locationNCT04984551
Recruiting
Phase 3

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

AnorexiaHematopoietic and Lymphoid Cell NeoplasmAdvanced Malignant Solid Neoplasm
Alliance for Clinical Trials in Oncology360 enrolled293 locationsNCT04939090
Recruiting

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

Malignant Solid NeoplasmSarcomaMelanoma+2 more
M.D. Anderson Cancer Center12,000 enrolled1 locationNCT01772771
Recruiting
Phase 3

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
Children's Oncology Group105 enrolled28 locationsNCT05711667
Recruiting

Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center170 enrolled1 locationNCT05108519
Recruiting
Phase 1

Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Hematopoietic and Lymphoid Cell NeoplasmImmunocompromised
M.D. Anderson Cancer Center16 enrolled1 locationNCT03425526
Recruiting

The Impact of COVID-19 on Pulmonary Procedures

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection
M.D. Anderson Cancer Center250 enrolled1 locationNCT05022446
Recruiting
Phase 2

Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients

Hematopoietic and Lymphoid Cell NeoplasmInfluenza
M.D. Anderson Cancer Center60 enrolled1 locationNCT04712539
Recruiting

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)

Hematopoietic and Lymphoid Cell NeoplasmBronchiolitis Obliterans Syndrome
Fred Hutchinson Cancer Center250 enrolled4 locationsNCT05250037